0102030405
CAS No 459868-92-9 Rucaparib phosphate Pharmaceutical Intermediates
02
overview
Rucaparib phosphate is an advanced pharmaceutical compound that has attracted much attention for its role in cancer treatment. This drug is specifically designed to inhibit the PARP enzyme, which plays a vital role in the DNA repair mechanism of cancer cells.
By targeting this pathway, Rucaparib phosphate may enhance the effectiveness of chemotherapy and help improve treatment outcomes for patients with advanced ovarian cancer.
A product of our integrated manufacturing and trading facility, Rucaparib phosphate embodies our commitment to quality, innovation and customer satisfaction.
By targeting this pathway, Rucaparib phosphate may enhance the effectiveness of chemotherapy and help improve treatment outcomes for patients with advanced ovarian cancer.
A product of our integrated manufacturing and trading facility, Rucaparib phosphate embodies our commitment to quality, innovation and customer satisfaction.
02
Physical and chemical properties
- Molecular weight: 421.37g/mol
- Solubility: Soluble in water and organic solvents, which is beneficial for various drug formulations.
- Stability: The compound exhibits good stability under standard storage conditions, ensuring a longer shelf life and maintaining its therapeutic effects.
These properties not only enhance the performance of Rucaparib phosphate in pharmaceutical formulations but also enhance its versatility for various applications in cancer therapy.
- Solubility: Soluble in water and organic solvents, which is beneficial for various drug formulations.
- Stability: The compound exhibits good stability under standard storage conditions, ensuring a longer shelf life and maintaining its therapeutic effects.
These properties not only enhance the performance of Rucaparib phosphate in pharmaceutical formulations but also enhance its versatility for various applications in cancer therapy.
1. Targeted cancer therapy: Rucaparib phosphate specifically targets cancer cells with BRCA mutations, providing a personalized treatment approach and enhancing the therapeutic effect.
2. Enhanced efficacy: By inhibiting the PARP enzyme, Rucaparib phosphate increases the sensitivity of cancer cells to DNA-damaging agents, making it a powerful adjunct to chemotherapy.
3. Convenient dosing regimen: Rucaparib phosphate is typically administered orally, providing a convenient dosing schedule that can improve patient compliance and overall treatment experience.
4. Proven Safety: Rucaparib phosphate has a well-established safety profile and is a trusted component of cancer treatment regimens. Its use is supported by extensive research and clinical studies to ensure that safety and efficacy standards are met.
5. Cost-effective: As a product of our integrated plant, Rucaparib phosphate is priced very competitively without compromising on quality. This cost-effectiveness makes it an attractive option for pharmaceutical companies and healthcare providers.
6. Sustainability: We are committed to sustainable manufacturing practices, ensuring that Rucaparib Phosphate is produced with minimal impact on the environment. We prioritize environmentally friendly processes and materials to meet the growing demand for sustainable pharmaceutical solutions.
2. Enhanced efficacy: By inhibiting the PARP enzyme, Rucaparib phosphate increases the sensitivity of cancer cells to DNA-damaging agents, making it a powerful adjunct to chemotherapy.
3. Convenient dosing regimen: Rucaparib phosphate is typically administered orally, providing a convenient dosing schedule that can improve patient compliance and overall treatment experience.
4. Proven Safety: Rucaparib phosphate has a well-established safety profile and is a trusted component of cancer treatment regimens. Its use is supported by extensive research and clinical studies to ensure that safety and efficacy standards are met.
5. Cost-effective: As a product of our integrated plant, Rucaparib phosphate is priced very competitively without compromising on quality. This cost-effectiveness makes it an attractive option for pharmaceutical companies and healthcare providers.
6. Sustainability: We are committed to sustainable manufacturing practices, ensuring that Rucaparib Phosphate is produced with minimal impact on the environment. We prioritize environmentally friendly processes and materials to meet the growing demand for sustainable pharmaceutical solutions.
In summary, due to its innovative mechanism of action, enhanced efficacy and strong safety, Rucaparib phosphate has become the first choice for the treatment of advanced ovarian cancer.
With Rucaparib phosphate, you can be confident that you are choosing a reliable and effective solution for your pharmaceutical needs.
As a factory integrating production and trading, we are committed to providing customers with high-quality products that meet the highest industry standards.
Work with us today to experience the benefits of Rucaparib phosphate and enhance your pharmaceutical supply in cancer treatment.
With Rucaparib phosphate, you can be confident that you are choosing a reliable and effective solution for your pharmaceutical needs.
As a factory integrating production and trading, we are committed to providing customers with high-quality products that meet the highest industry standards.
Work with us today to experience the benefits of Rucaparib phosphate and enhance your pharmaceutical supply in cancer treatment.